Clinical Trial Update: Age and Gender Effects on the Pharmacokinetics of BAY85-3934 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating how age and gender influence the pharmacokinetics of BAY85-3934 in anemia; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• BAY85-3934

Snippet

Sponsor: Bayer | Conditions: Anemia | Phase 1 | Status: COMPLETED